Skip to content

Female Hair Loss — Causes, Diagnosis, Treatment

40% of all women experience visible hair loss in their lifetime. The causes are more diverse than in men—and are often misdiagnosed or diagnosed too late. What you need to know about female hair loss.

How Female Hair Loss Differs from Male Hair Loss

Male hair loss follows a predictable pattern: receding hairline, bald spot on the crown, progressive loss according to the Norwood scale. For women, it's entirely different—and that's precisely what makes diagnosis more challenging.

Diffuse Thinning Instead of a Clear Pattern

In women, hair usually thins evenly in the part area. The hairline almost always remains intact. This makes the loss insidious—it's often only noticed when 30–50% of hair density has already been lost.

The "Christmas Tree Pattern"

Characteristic of female hair loss is the widening of the central part—wider at the front, narrowing towards the back. Like a Christmas tree viewed from above. This is the first clinical sign long before the scalp becomes visibly transparent.

More Causes, Less Definitive

While androgenetic alopecia is responsible for 90% of cases in men, women often experience a combination of hormonal shifts, deficiencies, stress, and genetic components. A single diagnosis is rarely sufficient.

Different Classification Needed

The Norwood scale is not suitable for women. Instead, the Ludwig scale, Sinclair, and Olsen classifications are used. This requires specialized expertise.

Different Treatment Options

DHT inhibitors are contraindicated in premenopausal women. Topical hair growth therapy is used in lower dosages. Instead, anti-androgens like anti-androgen therapy come into play. Hormone diagnostics are standard, not an exception.

The 8 Most Common Causes

1. Androgenetic Alopecia (FPHL — Female Pattern Hair Loss)

Hereditary, affecting approximately 40% of all women over their lifetime. Often begins postmenopausally, but sometimes as early as age 30. Diffuse thinning in the part area, hairline preserved.

2. Telogen Effluvium

Shifted hair cycle—more hairs than normal enter the resting phase simultaneously. Classic triggers: severe stress, acute illness, surgery, childbirth, dieting, significant weight loss. Occurs 2–3 months after the trigger. Usually reversible within 6–12 months.

3. Hormonal Changes

  • Postpartum — after pregnancy, affecting approximately 50% of women, resolves within 6–12 months
  • Menopause — estrogen declines, relative androgen excess, FPHL can worsen
  • Stopping the pill — hormonal changes can trigger telogen effluvium
  • PCOS — Polycystic Ovary Syndrome with elevated androgens leads to earlier and more severe hair loss

4. Iron Deficiency / Ferritin Deficiency

The most frequently overlooked cause in women. Ferritin should be above 70 ng/ml for healthy hair growth. Levels below 30 ng/ml clearly lead to hair loss, even without classic anemia symptoms. Common in menstruating individuals, vegetarians, vegans, and pregnant women.

5. Thyroid Disorders

Both hypo- and hyperthyroidism cause hair loss. Often undiagnosed for years. TSH levels are standard for any hair loss evaluation.

6. Medication-Induced

Birth control pills (change), antidepressants, beta-blockers, lithium, some cancer therapies, high-dose vitamin A preparations, anticoagulants. Review current list.

7. Autoimmune Diseases

  • Alopecia areata — circular, clearly defined bald patches
  • Lichen planopilaris — scarring hair loss, often at the frontal hairline
  • Frontal fibrosing alopecia — primarily postmenopausal, hairline recedes

8. Malnutrition / Crash Diets

Protein deficiency, zinc deficiency, biotin deficiency (rare), vitamin D deficiency. Common with very restrictive diets, after bariatric surgery, in eating disorders.

Diagnosis — What's Different for Women

For men, a visual examination and trichoscopy are often sufficient. For women, diagnosis is always multi-layered—otherwise, the causes will be missed.

Standard Diagnostics for Women

  1. In-depth anamnesis: Cycle, pregnancies, pill history, menopausal status, family history, stress levels, diets, medications
  2. Clinical examination: Classification according to Ludwig, Sinclair, and Olsen
  3. Trichoscopy: Detects miniaturization, scarring vs. non-scarring loss, inflammatory changes
  4. Pull test: Gently pulling hair strands—if more than 4–6 hairs come out, it indicates active telogen effluvium
  5. Blood analysis: Ferritin, Vitamin D, B12, Zinc, TSH, fT3/fT4, possibly hormone panel (testosterone, DHEAS, SHBG, androstenedione, prolactin) if androgen excess is suspected

When Extended Diagnostics Are Needed

  • For scarring hair loss: Scalp biopsy
  • If PCOS is suspected: Ultrasound of the ovaries
  • For younger women with significant androgen excess: Endocrinological clarification

Misdiagnoses We Often See

  • "You're just stressed"—without checking ferritin and thyroid levels
  • "Vitamin deficiency" without a blood test—general supplementation
  • "Genetic" without ruling out other causes
  • Transplantation recommended without clarifying hormonal causes

Hormonal Hair Loss — PCOS, Menopause, The Pill

PCOS — Polycystic Ovary Syndrome

The most common hormonal cause in young women. Characteristics: elevated androgens, often accompanied by irregular cycles, acne, hirsutism (excessive body hair), and insulin resistance. Hair loss typically follows the androgenetic pattern—part area thinning.

Treatment approaches: Antiandrogenic pill, anti-androgen therapy, metformin for insulin resistance, lifestyle adjustments. Hormonal therapy should be managed by a gynecologist or endocrinologist—we work interdisciplinarily.

Menopause / Perimenopause

From age 40, estrogen declines—at the same time, the ratio to androgens becomes relatively more androgenic. Result: existing androgenetic alopecia worsens, new cases appear.

Treatment approaches: Topical hair growth therapy (2%), with clear indication, low-dose oral hair growth therapy. Hormone replacement therapy (HRT) can reduce hair loss—but must be weighed individually with a gynecologist.

After Pregnancy (Postpartum Hair Loss)

Very common, affecting approximately 50% of women. Appears 2–4 months after birth. Background: During pregnancy, hairs remain in the anagen phase longer (high estrogen levels)—after birth, the "built-up" hairs fall out simultaneously.

Important: Postpartum hair loss is usually fully reversible. Resolves within 6–12 months. Still check iron status and thyroid levels—pregnancy can reduce both.

Stopping the Pill

Hormonal changes after stopping can trigger telogen effluvium—3–4 months after discontinuation. Usually reversible. However, if there is an existing androgenetic predisposition, stopping the pill can unmask the underlying FPHL.

Changing the Pill

Switching to a pill with an anti-androgenic component (e.g., drospirenone, cyproterone acetate) can help with androgenetic alopecia. Switching to a purely progestin-only pill can worsen hair loss. Discuss with a gynecologist.

Treatment Options for Women

1. Treating the Cause First

Before any symptomatic therapy, the underlying cause is treated. Iron deficiency substitution. Thyroid adjustment. Stress reduction. PCOS therapy. Pill change. Only when the underlying cause is resolved do further measures make sense.

2. Topical or Oral Hair Growth Therapy

  • Topical hair growth therapy in concentrations suitable for women—standard, twice daily
  • Topical hair growth therapy in higher concentration—can also be used in women with good tolerability, stronger effect, but higher risk of hypertrichosis
  • Oral low-dose hair growth therapy (off-label)—growing evidence, easier to use than the topical form

3. Anti-Androgens (for Androgenetic Component)

  • Anti-androgen therapy (100–200 mg/day)—antiandrogen, blocks androgen receptor, off-label for hair loss
  • Cyproterone acetate—often in combination with estrogen as an anti-androgenic pill
  • DHT inhibitors in postmenopausal women—off-label, under medical supervision

Important: Anti-androgens in women of childbearing age ONLY with reliable contraception.

4. PRP & Mesotherapy

Well-suited for women because there is no systemic hormonal effect. PRP in 3–4 sessions, then booster 1–2 times per year. Particularly effective combined with topical hair growth therapy.

5. Micronutrient Optimization

Supplementation for proven deficiency—iron until ferritin > 70, vitamin D to > 50, zinc, biotin only for deficiency, B12. General multi-vitamin supplementation brings little benefit.

6. Low-Level Laser Therapy

As an adjunct to drug therapy. Usually not sufficient alone, but well-tolerated for women who want to avoid medication.

Hair Transplantation in Women

A hair transplant is also possible in women and can achieve excellent results—but the indications are stricter and the procedure is different.

When a Transplant is Useful for Women

  • Localized thinning in androgenetic alopecia (Ludwig I–II)
  • Hairline correction for a high forehead or congenitally low hairline
  • Scar camouflage after surgery or trauma
  • Eyebrow restoration
  • Correction of a high forehead (pretrichial lift / forehead reduction)

When a Transplant is NOT Useful

  • For active telogen effluvium—first clarify the cause and stabilize the course
  • For unstable androgenetic alopecia—otherwise, surrounding areas will continue to thin
  • For diffuse thinning over the entire scalp—no good donor area
  • For scarring alopecias—risk of re-activation of inflammation
  • For acute hormonal changes (menopause, postpartum)—first stabilize

Special Features of Female Transplantation

  • Usually no shaving necessary—unshaven technique preferred
  • Lower number of grafts per session (typically 1,000–2,500)
  • Hairline design follows female anatomy (lower set, softer line)
  • Conservative concomitant therapy is mandatory, not optional
  • The course in the first 6 months can vary due to hormonal fluctuations

Special Case: Pretrichial Lift (Forehead Reduction)

For a very high forehead (trichion-glabella distance > 7 cm), instead of a transplant, an operative hairline relocation can be performed—the forehead skin is shortened, and the hairline moves down 1–2 cm. Different indication, different technique. Often combined with transplantation.

Myths About Female Hair Loss

Myth 1: "Women don't go bald"

False. Approximately 40% of women experience significant hair loss, about 10% of whom develop clinically relevant baldness in the part area. Very advanced stages (Ludwig III) are rarer than in men, but they do exist.

Myth 2: "Frequent washing is harmful"

False. Daily washing with a mild shampoo is not harmful—on the contrary, a clean scalp is a prerequisite for healthy hair growth. The hairs that fall out during washing would have fallen out anyway (telogen phase).

Myth 3: "Stress makes hair gray, but not fall out"

False. Stress is a very common cause of telogen effluvium—even in younger women. Delay of 2–3 months after the stress phase.

Myth 4: "Vegan women need to take biotin"

Nuanced: Biotin deficiency is very rare even in vegans. Iron, B12, and zinc deficiencies, however, are common—these are the critical values to check, not biotin.

Myth 5: "The pill causes hair loss"

It depends on the pill. Pills with an anti-androgenic component often protect against hair loss. Pure progestin-only pills or those with androgenic effects can promote hair loss. When discontinuing, temporary telogen effluvium can occur.

Myth 6: "Menopause = unavoidable hair loss"

False. Postmenopausal hair loss is also highly treatable—topical hair growth therapy, possibly low-dose DHT inhibitors, local therapies. Those who do nothing lose more than necessary.

Myth 7: "Women don't need a transplant"

False. With the correct indication, transplantation is one of the most effective options for women with localized thinning or hairline problems. Approximately 30–40% of our transplant patients are women.

Unsure if multiple causes apply to you? Our hair check guides you through a few questions and provides an initial specialist assessment—start self-check.

Frequently Asked Questions

Is hair loss common in women?

Yes, significantly more common than often assumed. Approximately 40% of women experience visible hair loss during their lifetime. The incidence increases sharply after menopause.

What are the most common causes?

In women, the causes are more diverse than in men. Most common: androgenetic alopecia, telogen effluvium (stress, postpartum), iron deficiency, thyroid disorders, hormonal changes (PCOS, menopause). Often combinations.

Which doctor is responsible?

First point of contact: Dermatologist specializing in hair. Depending on the findings, interdisciplinarily with a gynecologist (hormonal causes), endocrinologist (thyroid, androgens), internist (deficiencies). A good hair medical specialist coordinates this.

Does topical hair growth therapy help women?

Yes—topical hair growth therapy is standard therapy and also works well in women. With good tolerability, topical hair growth therapy is also possible. The effect can be assessed after 4–6 months. If discontinued, the effect disappears again.

Can I, as a woman, take DHT inhibitors?

Women of childbearing age: absolutely not—DHT inhibitors cause severe malformations in male fetuses. Postmenopausal women: yes, off-label and under medical supervision. Alternative: anti-androgen therapy as an antiandrogen.

How long does postpartum hair loss last?

Begins 2–4 months after birth. Usually resolves completely within 6–12 months. No need to panic during this phase. However, iron and thyroid should still be checked.

Can I, as a woman, get a hair transplant?

Yes, with the correct indication. Approximately 30–40% of our transplant patients are women. Prerequisites: stabilized underlying condition, good donor area quality, localized (not diffuse) loss. Procedure and hairline design follow female anatomy.

When should I see a doctor?

If you lose more than 100 hairs per day (home pull test), with visible widening of the central part, with circular hair loss, with hair loss in combination with menstrual cycle disorders, fatigue, weight changes. Early clarification significantly increases the chances of recovery.

Appointment Booking

Wird geladen...